Puneet Souda
Stock Analyst at Leerink Partners
(4.26)
# 1,433
Out of 5,023 analysts
929
Total ratings
46.3%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Reiterated: Buy | $80 | $63.24 | +26.50% | 50 | Sep 29, 2026 | |
| ILMN Illumina | Reiterated: Buy | $210 → $300 | $273.04 | +9.87% | 83 | Sep 29, 2026 | |
| TWST Twist Bioscience | Reiterated: Buy | $160 → $190 | $188.67 | +0.70% | 34 | Sep 29, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | $40 → $90 | $93.50 | -3.74% | 13 | Sep 29, 2026 | |
| SVRN SVRN, Inc. | Reiterated: Buy | n/a | $36.16 | - | 2 | Sep 17, 2026 | |
| NTRA Natera | Reiterated: Buy | $330 | $410.35 | -19.58% | 66 | Aug 7, 2026 | |
| RVTY Revvity | Reiterated: Buy | n/a | $151.53 | - | 15 | Jul 17, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | $73 | $72.40 | +0.83% | 44 | Jun 25, 2026 | |
| GH Guardant Health | Reiterated: Buy | n/a | $177.80 | - | 67 | Jun 2, 2026 | |
| ALMR Alamar Biosciences | Initiated Coverage: Buy | $35 | $34.36 | +1.86% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $14 → $25 | $18.47 | +35.35% | 50 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $500 → $580 | $654.80 | -11.42% | 50 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $235 | $214.06 | +9.78% | 18 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $181.70 | n/a | 42 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $3.64 | n/a | 60 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $167.78 | n/a | 39 | Sep 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.87 | n/a | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $45.81 | n/a | 40 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $16 | $17.43 | n/a | 33 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 → $12 | $12.69 | n/a | 40 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $4.54 | n/a | 33 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $35.60 | n/a | 48 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 | $425.21 | n/a | 38 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.95 | n/a | 1 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.56 | n/a | 1 | Jun 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $13.74 | n/a | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $37.70 | n/a | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $35.00 | n/a | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $20.65 | n/a | 1 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.000001 | n/a | 7 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.0006 | n/a | 9 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $23.49 | n/a | 1 | Oct 20, 2014 |
Bruker
Sep 29, 2026
Reiterated: Buy
Price Target: $80
Current: $63.24
Upside: +26.50%
Illumina
Sep 29, 2026
Reiterated: Buy
Price Target: $210 → $300
Current: $273.04
Upside: +9.87%
Twist Bioscience
Sep 29, 2026
Reiterated: Buy
Price Target: $160 → $190
Current: $188.67
Upside: +0.70%
10x Genomics
Sep 29, 2026
Reiterated: Hold
Price Target: $40 → $90
Current: $93.50
Upside: -3.74%
SVRN, Inc.
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $36.16
Upside: -
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: $330
Current: $410.35
Upside: -19.58%
Revvity
Jul 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $151.53
Upside: -
Bio-Techne
Jun 25, 2026
Downgraded: Hold
Price Target: $73
Current: $72.40
Upside: +0.83%
Guardant Health
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $177.80
Upside: -
Alamar Biosciences
May 12, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $34.36
Upside: +1.86%
Apr 29, 2026
Upgraded: Buy
Price Target: $14 → $25
Current: $18.47
Upside: +35.35%
Oct 23, 2025
Reiterated: Buy
Price Target: $500 → $580
Current: $654.80
Upside: -11.42%
Oct 22, 2025
Reiterated: Buy
Price Target: $235
Current: $214.06
Upside: +9.78%
Sep 11, 2025
Reiterated: Buy
Price Target: $200
Current: $181.70
Upside: n/a
Sep 10, 2025
Reiterated: Hold
Price Target: $6
Current: $3.64
Upside: n/a
Sep 1, 2025
Reiterated: Buy
Price Target: $140
Current: $167.78
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $10
Current: $4.87
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $45
Current: $45.81
Upside: n/a
Aug 6, 2025
Upgraded: Buy
Price Target: $10 → $16
Current: $17.43
Upside: n/a
Aug 6, 2025
Upgraded: Buy
Price Target: $7 → $12
Current: $12.69
Upside: n/a
Aug 6, 2025
Reiterated: Hold
Price Target: $9
Current: $4.54
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $35
Current: $35.60
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $340
Current: $425.21
Upside: n/a
Jul 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $5.95
Upside: n/a
Jun 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.56
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $5
Current: $13.74
Upside: n/a
May 7, 2024
Reiterated: Buy
Price Target: n/a
Current: $37.70
Upside: n/a
Dec 19, 2023
Reiterated: Buy
Price Target: n/a
Current: $35.00
Upside: n/a
Apr 29, 2022
Reiterated: Buy
Price Target: $16
Current: $20.65
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: $3
Current: $0.0006
Upside: n/a
Oct 20, 2014
Reiterated: Buy
Price Target: $80
Current: $23.49
Upside: n/a